A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors

Raoul Tibes, Gil D. Fine, Gavin Choy, Sanjeev Redkar, Pietro Taverna, Aram Oganesian, Amarpal Sahai, Mohammad Azab, Anthony W. Tolcher

Cancer Chemotherapy and Pharmacology · 2012 · 26 citations · 18 references

Concepts

References

18